Dejan Budimirovic

Associate Professor

Johns Hopkins University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dejan Budimirovic is an Associate Professor at Johns Hopkins University, United States. His research primarily focuses on fragile X syndrome and includes exploring targeted drug development, the role of the endocannabinoid system, and behavioral analyses using Drosophila melanogaster models. Dr. Budimirovic's recent publications highlight advancements in understanding social interactions, circadian rhythms, and clinical treatment trials in the context of fragile X-associated disorders.

Articles (14)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (9)

Frank Kooy

Professor

University of Antwerp

BELGIUM

View details

Joseph Palumbo

Member, Dean's Council of Advisors

The George Washington University School of Medicine and Health SCiences

UNITED STATES

View details

Peng Jin

Emory University

UNITED STATES

View details

Christopher Faulk

University of Minnesota

UNITED STATES

View details

Peter Todd

University of Michigan

UNITED STATES

View details

Walter Kaufmann

Emory University

UNITED STATES

View details

David Hessl

Professor

University of California, Davis

UNITED STATES

View details

randi hagerman

Professor

University of California, Davis

UNITED STATES

View details

Flora Tassone

University of California, Davis

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dejan Budimirovic

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Targeted drug development in fragile X syndrome: Molecular medicine as a key tool in clinical pharmacology

Circadian Rhythm and Sleep Analyses in a Fruit Fly Model of Fragile X Syndrome Using a Video-Based Automated Behavioral Research System

Using a Combination of Novel Research Tools to Understand Social Interaction in the Drosophila melanogaster Model for Fragile X Syndrome

Role of the endocannabinoid system in fragile X syndrome: potential mechanisms for benefit from cannabidiol treatment.

Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on <i>FMR1</i> Premutation

Drosophila melanogaster as a Model to Study Fragile X-Associated Disorders

Latent Class Analysis Identifies Distinctive Behavioral Subtypes in Children with Fragile X Syndrome.

A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX).

Fragile X Syndrome: Recent Research Updates toward Capturing Treatments' Improvement in Clinical Trials.

Sleep problems in fragile X syndrome: Cross‐sectional analysis of a large clinic‐based cohort

Height and BMI in fragile X syndrome: A longitudinal assessment.

Fragile X Syndrome: From Molecular Aspect to Clinical Treatment

Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study

Increasing Interest in Child and Adolescent Psychiatry Through a Structured Tutorial Program

Collaborators (9)

Frank Kooy

Joseph Palumbo

Peng Jin

Christopher Faulk

Peter Todd

Walter Kaufmann

David Hessl

randi hagerman

Flora Tassone

Make your next move.